Barclays Maintains Overweight on Corteva, Raises Price Target to $91

Benzinga Newsdesk www.benzinga.com Positive 80.3%

Neg 0% Neu 0% Pos 80.3%

Barclays analyst Benjamin Theurer maintains Corteva (NYSE:CTVA) with a Overweight and raises the price target from $84 to $91.